A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

The U.S. Food and Drug Administration is warning Americans about the ever-increasing and potentially deadly recreational use ...

As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Study shows higher teen alcohol use in Illinois. A study conducted by the Center for Prevention Research and Development at ...

The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy.  The report, ...

Opposing interests in the health care world are escalating their fight over an Illinois bill on the 340B drug discount ...